Claris Lifesciences has informed that a meeting of the board of directors of the company will be held on February 23, 2013, to consider and take on record the annual audited financial results of the company for the year ended December 31, 2012 and recommendation of dividend if any, for the year ended December 31, 2012.
The above information is a part of company’s filings submitted to BSE.